Amarin Corp Plc (AMRN)

[dukesking]

BobWayne, That seems to be the case for most non vaccine treatments. I believe we would need another trial to get FDA approval. Positive results of P1&2 should still create positive brand recognition and interest amongst doctors and consumers and increased script requests by patients with CVD and risk factors. Maybe I’m just dreaming. Look what speculation has done for Hydroxychloroquine, vitamin D, zinc, Ivermectin, and others. Everybody with risk factors are aware of these names regardless of wether they’re effective or not. If people find out Vascepa has positive effects against CV19, it should become a household name and increase script request that will more likely be written, filled and covered. There will most likely be resistance and FUD but it won’t stop people from asking their doctors for a script. US and EU would gobble up all Amarin can produce.Thanks for letting me lay out my dream scenario and prediction. Let a dude dream!